NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Tuesday reported fourth-quarter net income of $208 million.
The New York-based company said it had net income of 35 cents per share. Earnings, adjusted for non-recurring costs, came to $1.15 per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.09 per share.
The company posted revenue of $594 million in the period. Its adjusted revenue was $742 million.
For the year, the company reported profit of $859 million, or $1.45 per share. Revenue was reported as $2.8 billion.
Royalty Pharma expects full-year revenue in the range of $2.9 billion to $3.05 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
